162 results
Page 3 of 9
8-K
EX-10.01
srmlkwm55a4 yw8xk
26 Jan 22
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
8:05am
8-K
EX-99.1
s1z4z71 82uou5iucazi
25 Feb 21
Adaptimmune Reports Fourth Quarter / Full Year 2020 Financial Results and Business Update
7:37am
8-K
EX-10.1
w1fnfm
16 Dec 20
Departure of Directors or Certain Officers
5:01pm
8-K
EX-99.1
v7zf38zvthr8u7
20 Nov 20
Regulation FD Disclosure
7:36am
8-K
mpxhv446pgb
20 Nov 20
Regulation FD Disclosure
7:36am
8-K
EX-99.1
ibk fkaw21m30lo
5 Nov 20
Adaptimmune Reports Q3 Financial Results and Business Update
7:40am
S-3ASR
nex nw65s
10 Aug 20
Automatic shelf registration
5:01pm
S-3ASR
EX-1.2
2n1t xtcr9
10 Aug 20
Automatic shelf registration
5:01pm
8-K
EX-99.1
leucc0fv3r
6 Aug 20
Adaptimmune Reports Q2 Financial Results and Business Update
7:37am
424B5
zhvw92rdxdoj 6d
2 Jun 20
Prospectus supplement for primary offering
5:05pm
8-K
EX-1.1
abectq9
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm